|
[Related PubMed/MEDLINE]
Total Number of Papers: 245
|
|
|
|
|
[Display Entries]
|
|
|
| |
|
[Entries Per Page]
|
|
per page
|
| |
|
Page Control
|
|
|
|
Page: of
|
|
|
|
| Abbreviation |
: HGGs |
| Long Form |
: high-grade gliomas |
|
| No. |
Year |
Title |
Co-occurring Abbreviation |
| 1 |
2020 |
A Novel Deep Learning Algorithm for the Automatic Detection of High-Grade Gliomas on T2-Weighted Magnetic Resonance Images: A Preliminary Machine Learning Study. |
CNN, MRI |
| 2 |
2020 |
A radiomics-based comparative study on arterial spin labeling and dynamic susceptibility contrast perfusion-weighted imaging in gliomas. |
ASL, DSC, LGGs |
| 3 |
2020 |
A simple model for glioma grading based on texture analysis applied to conventional brain MRI. |
GLSZM, LGGs |
| 4 |
2020 |
Association of tumor growth rates with molecular biomarker status: a longitudinal study of high-grade glioma. |
MRIs |
| 5 |
2020 |
Cerebral hemispheric glioblastoma with PNET-like morphology and histone H3.3 G34 mutation in younger patients: Report of three rare cases and diagnostic pitfalls. |
GBM |
| 6 |
2020 |
Comparison of amide proton transfer imaging and magnetization transfer imaging in revealing glioma grades and proliferative activities: a histogram analysis. |
LGGs, MT, MTR |
| 7 |
2020 |
Conventional MR and DW imaging findings of cerebellar primary CNS lymphoma: comparison with high-grade glioma. |
ADC, PCNSLs |
| 8 |
2020 |
Corrigendum to "Protoporphyrin IX tracer fluorescence modulation for improved brain tumor cell lines visualization". |
5-ALA, ABCG2, FECH, FIGR, HO-1, LGGs, PpIX |
| 9 |
2020 |
Current clinical management of elderly patients with glioma. |
--- |
| 10 |
2020 |
Differentiating High-Grade Gliomas from Brain Metastases at Magnetic Resonance: The Role of Texture Analysis of the Peritumoral Zone. |
BMs, MRI |
| 11 |
2020 |
Diffusion kurtosis imaging differs between primary central nervous system lymphoma and high-grade glioma and is correlated with the diverse nuclear-to-cytoplasmic ratio: a histopathologic, biopsy-based study. |
DKI, FA, MD, MK, N/C, PCNSLs |
| 12 |
2020 |
Effect of valproic acid on overall survival in patients with high-grade gliomas undergoing temozolomide: A nationwide population-based cohort study in Taiwan. |
DDD, OS, TMZ, VPA |
| 13 |
2020 |
Effects of supra-total resection in neurocognitive and oncological outcome of high-grade gliomas comparing asleep and awake surgery. |
EOR, OS |
| 14 |
2020 |
Evaluating H3F3A K27M and G34R/V somatic mutations in a cohort of pediatric brain tumors of different and rare histologies. |
CNS, DNETs |
| 15 |
2020 |
Everolimus improves the efficacy of dasatinib in PDGFRalpha-driven glioma. |
--- |
| 16 |
2020 |
FKBP9 promotes the malignant behavior of glioblastoma cells and confers resistance to endoplasmic reticulum stress inducers. |
CAM, ER, FKBP9, GBM, IB, IHC |
| 17 |
2020 |
Gene therapies for high-grade gliomas: from the bench to the bedside. |
--- |
| 18 |
2020 |
Grading of Glioma: combined diagnostic value of amide proton transfer weighted, arterial spin labeling and diffusion weighted magnetic resonance imaging. |
APT, APT, ASL, AUC, DWI, LGGs, MRI, rCBF 90th, rCBF mean, ROC |
| 19 |
2020 |
High-grade gliomas in adolescents and young adults highlight histomolecular differences from their adult and pediatric counterparts. |
AYAs, IDH, WHO |
| 20 |
2020 |
Histone Deacetylase Inhibitors in Pediatric Brain Cancers: Biological Activities and Therapeutic Potential. |
ATRTs, EPN, HDACIs, MB |
| 21 |
2020 |
Hypoxia, metabolism, and the circadian clock: new links to overcome radiation resistance in high-grade gliomas. |
HIF-1 |
| 22 |
2020 |
Infantile/Congenital High-Grade Gliomas: Molecular Features and Therapeutic Perspectives. |
--- |
| 23 |
2020 |
Intraoperative MRI versus 5-ALA in high-grade glioma resection: a network meta-analysis. |
5-ALA, EOR, GTR, IMRI |
| 24 |
2020 |
Ki-67 labeling index and the grading of cerebral gliomas by using intravoxel incoherent motion diffusion-weighted imaging and three-dimensional arterial spin labeling magnetic resonance imaging. |
ADC, CBF, IVIM-DWI, Ki-67 LI, LGGs, MRI, ROC |
| 25 |
2020 |
MicroRNA-1298-3p inhibits proliferation and invasion of glioma cells by downregulating Nidogen-1. |
DEMs, LGGs, NID1 |
| 26 |
2020 |
Molecular and Immunologic Signatures are Related to Clinical Benefit from Treatment with Vocimagene Amiretrorepvec (Toca 511) and 5-Fluorocytosine (Toca FC) in Patients with Glioma. |
--- |
| 27 |
2020 |
MRimaging by 3D T1-weighted black blood sequences may improve delineation of therapy-naive high-grade gliomas. |
BB, CE, CNRs, MRI, TFE, WHO |
| 28 |
2020 |
Multiparametric MR-PET measurements in hypermetabolic regions reflect differences in molecular status and tumor grade in treatment-naive diffuse gliomas. |
ADC, AUC, FDOPA, FLAIRROI, IDH, LGGs, MRI, nSUVmax, PET, rCBV, ROIs |
| 29 |
2020 |
Natural history of de novo high grade glioma: first description of growth parabola. |
LGGs, MRI, MTD, VDE |
| 30 |
2020 |
Palliative Care in Patients With High-Grade Gliomas in the Neurological Intensive Care Unit. |
CI, DNR, NICU, OR, PCC |
| 31 |
2020 |
Pediatric Diffuse Midline Gliomas H3 K27M-Mutant and Non-Histone Mutant Midline High-Grade Gliomas in Neurofibromatosis Type 1 in Comparison With Non-Syndromic Children: A Single-Center Pilot Study. |
NF1, OS, PFS |
| 32 |
2020 |
Permanent iodine-125 brachytherapy for patients with progressive or recurrent high-grade gliomas. |
KPS, OS, PFS |
| 33 |
2020 |
Pretreatment structural and arterial spin labeling MRI is predictive for p53 mutation in high-grade gliomas. |
ASL, CBF, ETCM |
| 34 |
2020 |
Radiation dose-escalation and dose-fractionation modulate the immune microenvironment, cancer stem cells and vasculature in experimental high-grade gliomas. |
GSCs, mMDSCs, NS, RT, TAMs |
| 35 |
2020 |
Radiosensitization of high-grade gliomas through induced hyperthermia: Review of clinical experience and the potential role of MR-guided focused ultrasound. |
HT, MRgFUS, RT |
| 36 |
2020 |
Spinal cord anaplastic astrocytoma with BRAF V600E mutation: A case report and review of literature. |
--- |
| 37 |
2020 |
Targeting tumor hypoxia and mitochondrial metabolism with anti-parasitic drugs to improve radiation response in high-grade gliomas. |
GSCs, HIFs, OCR |
| 38 |
2019 |
5-ALA and FDA approval for glioma surgery. |
5-ALA, FDA |
| 39 |
2019 |
5-aminolevulinic acid photodynamic therapy for the treatment of high-grade gliomas. |
5-ALA, FDA, PDT |
| 40 |
2019 |
A Pilot Study of Vaccine Therapy with Multiple Glioma Oncoantigen/Glioma Angiogenesis-Associated Antigen Peptides for Patients with Recurrent/Progressive High-Grade Glioma. |
GAAA, GOA, VEGFR |
| 41 |
2019 |
An evidence-based approach to evaluate the accuracy of amide proton transfer-weighted MRI in characterization of gliomas. |
APT, CI, LGGs, MD, RCT, SI |
| 42 |
2019 |
Application of presurgical navigated transcranial magnetic stimulation motor mapping for adjuvant radiotherapy planning in patients with high-grade gliomas. |
DVH, nTMS, OAR, PTV, RT |
| 43 |
2019 |
Biological intratumoral therapy for the high-grade glioma part II: vector- and cell-based therapies and radioimmunotherapy. |
--- |
| 44 |
2019 |
Can dynamic contrast-enhanced MRI evaluate VEGF expression in brain glioma? An MRI-guided stereotactic biopsy study. |
DCE-MRI, LGGs, Ve, VEGF, Vp |
| 45 |
2019 |
Cell-free circulating tumor DNA in patients with high-grade glioma as diagnostic biomarker - A guide to future directive. |
SNVs |
| 46 |
2019 |
Cho/Cr ratio at MR spectroscopy as a biomarker for cellular proliferation activity and prognosis in glioma: correlation with the expression of minichromosome maintenance protein 2. |
Cho, Cr, LI, MCM2, MR, NAA, ROC |
| 47 |
2019 |
Combined Use of 5-Aminolevulinic Acid and Intraoperative Low-Field Magnetic Resonance Imaging in High-Grade Glioma Surgery. |
5-ALA, GTR, iMRI |
| 48 |
2019 |
CT-2A neurospheres-derived high-grade glioma in mice: a new model to address tumor stem cells and immunosuppression. |
GSCs, ML |
| 49 |
2019 |
Diagnostic accuracy of dynamic contrast-enhanced perfusion MRI in stratifying gliomas: A systematic review and meta-analysis. |
DCE, LGGs, MRI, PCNSLs |
| 50 |
2019 |
Diagnostic and grading accuracy of 18F-FDOPA PET and PET/CT in patients with gliomas: a systematic review and meta-analysis. |
LGGs, PET, PET/CT, SROC |
| 51 |
2019 |
DIVERSet JAG Compounds Inhibit Topoisomerase II and Are Effective Against Adult and Pediatric High-Grade Gliomas. |
HIF |
| 52 |
2019 |
Glioma grading and IDH1 mutational status: assessment by intravoxel incoherent motion MRI. |
ADC, IDH1, IVIM, LGGs, MRI, ROC |
| 53 |
2019 |
Healthcare Costs for High-grade Glioma. |
--- |
| 54 |
2019 |
Identification of genes functionally involved in the detrimental effects of mutant histone H3.3-K27M in Drosophila melanogaster. |
--- |
| 55 |
2019 |
Intergrating conventional MRI, texture analysis of dynamic contrast-enhanced MRI, and susceptibility weighted imaging for glioma grading. |
AUC, DCE-MRI, ITSS, LGGs, MRI, SWI, TA |
| 56 |
2019 |
IP1867B suppresses the insulin-like growth factor 1 receptor (IGF1R) ablating epidermal growth factor receptor inhibitor resistance in adult high grade gliomas. |
IGF1R |
| 57 |
2019 |
Long-term outcome data from 121 patients treated with Gamma Knife stereotactic radiosurgery as salvage therapy for focally recurrent high-grade gliomas. |
GKSRS, OS, PFS |
| 58 |
2019 |
Multimodal Surgical Treatment of High-Grade Gliomas in the Motor Area: The Impact of the Combination of Navigated Transcranial Magnetic Stimulation and Fluorescein-Guided Resection. |
IONM, nTMS |
| 59 |
2019 |
Neutrophil-lymphocyte ratio dynamics are useful for distinguishing between recurrence and pseudoprogression in high-grade gliomas. |
ePD, NLR, PsPD, TMZ |
| 60 |
2019 |
Perfusion, Diffusion, Or Brain Tumor Barrier Integrity: Which Represents The Glioma Features Best? |
DCE-MRI, IVIM-DWI, LGGs, OS, ROC |
| 61 |
2019 |
Plasma and brain pharmacokinetics of letrozole and drug interaction studies with temozolomide in NOD-scid gamma mice and sprague dawley rats. |
ECF, NSG, PK, TMZ |
| 62 |
2019 |
Platelet-Derived Growth Factor Receptor and Ionizing Radiation in High Grade Glioma Cell Lines. |
GFRs, PDGF, PDGFRs, PI3K |
| 63 |
2019 |
Pneumocystis jirovecii prophylaxis in patients treated for high-grade gliomas: a survey among neuro-oncologists. |
ALC, PJP |
| 64 |
2019 |
Preoperative systemic inflammatory markers in low- and high-grade gliomas: A retrospective analysis of 171 patients. |
LMR, NLR, PLR |
| 65 |
2019 |
Protoporphyrin IX tracer fluorescence modulation for improved brain tumor cell lines visualization. |
5-ALA, ABCG2, FIGR, LGGs, PpIX |
| 66 |
2019 |
Surgery of malignant motor-eloquent gliomas guided by sodium-fluorescein and navigated transcranial magnetic stimulation: a novel technique to increase the maximal safe resection. |
CST, EOR, FGR, GTR, IONM, nTMS |
| 67 |
2019 |
Survival after radiation therapy for high-grade glioma. |
IMRT |
| 68 |
2019 |
The Role of Fibrinogen-Like Protein 2 on Immunosuppression and Malignant Progression in Glioma. |
FGL2, FOXP3, LGGs |
| 69 |
2019 |
The value of arterial spin labelling in adults glioma grading: systematic review and meta-analysis. |
ASL, HROC, LGGs, QUADAS-2, rTBF, TBF |
| 70 |
2019 |
The value of visible 5-ALA fluorescence and quantitative protoporphyrin IX analysis for improved surgery of suspected low-grade gliomas. |
5-ALA, CPpIX, LGG, PpIX |
| 71 |
2019 |
Tumor-associated status epilepticus in patients with glioma: Clinical characteristics and outcomes. |
mRS, RSE, SE, SRSE, TASE |
| 72 |
2019 |
Young adults diagnosed with high grade gliomas: Patterns of care, outcomes, and impact on employment. |
OS, PFS |
| 73 |
2018 |
An evidence-based approach to assess the accuracy of diffusion kurtosis imaging in characterization of gliomas. |
AUC, CI, CNKI, DKI, DOR, LGGs, SEN, SPE |
| 74 |
2018 |
An evidence-based approach to assess the accuracy of intravoxel incoherent motion imaging for the grading of brain tumors. |
ADC, CI, IVIM, LGGs, MD, TP |
| 75 |
2018 |
Anthropometrics and Body Composition in Adults with High-Grade Gliomas: Effects of Disease-Related Variables. |
CG, FFM, FM |
| 76 |
2018 |
Arterial spin labeling perfusion: Prospective MR imaging in differentiating neoplastic from non-neoplastic intra-axial brain lesions. |
ASL, CBF, CWM, PE |
| 77 |
2018 |
Blood-Brain Barrier Disruption, Sodium Fluorescein, And Fluorescence-Guided Surgery Of Gliomas. |
IHC, LGG, SF |
| 78 |
2018 |
Clinical efficacy of simplified intravoxel incoherent motion imaging using three b-values for differentiating high- and low-grade gliomas. |
D-min, f-max, IVIM, LGGs, SIs |
| 79 |
2018 |
Clinical significance of FBXO17 gene expression in high-grade glioma. |
OS |
| 80 |
2018 |
Combining Clinical and Molecular Data to Predict the Benefits of Carmustine Wafers in Newly Diagnosed High-Grade Gliomas. |
CWs |
| 81 |
2018 |
Diagnostic value of apparent diffusion coefficient in differentiating between high-grade gliomas and brain metastases. |
BMs, DWI, MRI, ROC |
| 82 |
2018 |
Differentiation between vasogenic edema and infiltrative tumor in patients with high-grade gliomas using texture patch-based analysis. |
DCE, DTI, SVM, VOIs, Vp |
| 83 |
2018 |
Diffusion Tensor Imaging Shows Corpus Callosum Differences between High-Grade Gliomas and Metastases. |
AD, CC, DTI, FA, MD, METs, MRI, ROI |
| 84 |
2018 |
Digital Polymerase Chain Reaction Quantification of SERPINA1 Predicts Prognosis in High-Grade Glioma. |
FFPE, PCR, WHO |
| 85 |
2018 |
Effectiveness of Stereotactic Radiotherapy and Bevacizumab for Recurrent High-Grade Gliomas: A Potential Therapy for Isocitrate Dehydrogenase Wild-Type Recurrent High-Grade Gliomas. |
SRT-Bv |
| 86 |
2018 |
Efficacy and safety analysis on dendritic cell-based vaccine-treated high-grade glioma patients: a systematic review and meta-analysis. |
AEs, CT group, DC, NRS, OS, PFS, RCTs |
| 87 |
2018 |
End-of-Life Care in High-Grade Glioma Patients. The Palliative and Supportive Perspective. |
EOL, QOL |
| 88 |
2018 |
Extensive Molecular and Clinical Heterogeneity in Patients With Histologically Diagnosed CNS-PNET Treated as a Single Entity: A Report From the Children's Oncology Group Randomized ACNS0332 Trial. |
EFS, PBL |
| 89 |
2018 |
First-in-human evaluation of the Cleveland Multiport Catheter for convection-enhanced delivery of topotecan in recurrent high-grade glioma: results of pilot trial 1. |
CMC, Gd-DTPA, Vd |
| 90 |
2018 |
Investigational PET tracers for high-grade gliomas. |
EGFR, GBM, MRI, PET, TCA, TSPO, VEGF |
| 91 |
2018 |
Microglia Induce PDGFRB Expression in Glioma Cells to Enhance Their Migratory Capacity. |
BM, GBMs, PDGF, PDGFRs |
| 92 |
2018 |
Minimally Invasive Resection of Deep-seated High-grade Gliomas Using Tubular Retractors and Exoscopic Visualization. |
KPS |
| 93 |
2018 |
On differentiation between vasogenic edema and non-enhancing tumor in high-grade glioma patients using a support vector machine classifier based upon pre and post-surgery MRI images. |
ROC, SVM |
| 94 |
2018 |
Overview on current treatment standards in high-grade gliomas. |
EGFR, ICIs |
| 95 |
2018 |
Patterns of Clinical Use of Stereotactic Laser Ablation: Analysis of a Multicenter Prospective Registry. |
LAANTERN, SLA |
| 96 |
2018 |
PD-1 inhibition has only limited clinical benefit in patients with recurrent high-grade glioma. |
CI, mPFS |
| 97 |
2018 |
Phase I/II trial of vorinostat, bevacizumab, and daily temozolomide for recurrent malignant gliomas. |
BEV, DLTs, GBM, MTD, TMZ, VOR |
| 98 |
2018 |
Primary CNS Lymphomas: Challenges in Diagnosis and Monitoring. |
CSF, FDG-PET, MRI, PCNSL, TDLs |
| 99 |
2018 |
Prognostic Factors in Elderly Patients with High-grade Gliomas: A Retrospective Analysis of 24 Cases. |
KPS |
| 100 |
2018 |
Quantitative analysis of neurite orientation dispersion and density imaging in grading gliomas and detecting IDH-1 gene mutation status. |
icvf, IDH-1, LGGs, NODDI, ODI, PT, TP |
|
A Search Service for Abbreviation / Long Form
